BeOne Medicines Ltd.
Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –
BeOne Medicines Amgen R&D Cost-Share Liability — Current Portion by Year
Amgen R&D Cost-Share Liability — Current Portion ($M) ($M)
BeOne Medicines Amgen R&D Cost-Share Liability — Current Portion: $64.3M in FY2025, down 42.2% from a year earlier.
Where the FY2025 figure comes from
Source: Form 10-Q (filed 2026-08-05) ↗
Reported in Form 10-Q / 10-K Collaborative Arrangements Note (XBRL).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Amgen R&D Cost-Share Liability — Current Portion ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 64.3 | -42.2% | Form 10-Q (filed 2026-08-05) ↗ |
| FY2024 | Dec 31, 2024 | 111 | +63.5% | Form 10-K (filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 68 | -40.5% | Form 10-K (filed 2025-02-27) ↗ |
| FY2022 | Dec 31, 2022 | 114 | -5.4% | Form 10-K (filed 2024-02-26) ↗ |
| FY2021 | Dec 31, 2021 | 121 | -5.5% | Form 10-K (filed 2023-02-27) ↗ |
| FY2020 | Dec 31, 2020 | 128 | – | Form 10-K (filed 2022-02-28) ↗ |
| FY2019 | Dec 31, 2019 | 0 | – | Form 10-K (filed 2021-02-25) ↗ |
Cite this data
StockData. (2026). BeOne Medicines Amgen R&D Cost-Share Liability — Current Portion ($M), annual FY2019–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/amgen-fin-liab-cur
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.